The University of Chicago Header Logo

Connection

Ralph Weichselbaum to Cell Survival

This is a "connection" page, showing publications Ralph Weichselbaum has written about Cell Survival.
Connection Strength

2.192
  1. Tumor-reprogrammed resident T cells resist radiation to control tumors. Nat Commun. 2019 09 02; 10(1):3959.
    View in: PubMed
    Score: 0.126
  2. The contribution of DNA ploidy to radiation sensitivity in human tumour cell lines. Br J Cancer. 1999 Feb; 79(5-6):744-7.
    View in: PubMed
    Score: 0.121
  3. ROS modifiers and NOX4 affect the expression of the survivin-associated radio-adaptive response. Free Radic Biol Med. 2018 08 01; 123:39-52.
    View in: PubMed
    Score: 0.115
  4. Loss of ceramide production confers resistance to radiation-induced apoptosis. Cancer Res. 1997 Apr 01; 57(7):1270-5.
    View in: PubMed
    Score: 0.107
  5. C-jun and Egr-1 participate in DNA synthesis and cell survival in response to ionizing radiation exposure. J Biol Chem. 1995 Dec 22; 270(51):30303-9.
    View in: PubMed
    Score: 0.098
  6. RIG-I-like receptor LGP2 protects tumor cells from ionizing radiation. Proc Natl Acad Sci U S A. 2014 Jan 28; 111(4):E484-91.
    View in: PubMed
    Score: 0.085
  7. A survivin-associated adaptive response in radiation therapy. Cancer Res. 2013 Jul 15; 73(14):4418-28.
    View in: PubMed
    Score: 0.081
  8. A manganese superoxide dismutase (SOD2)-mediated adaptive response. Radiat Res. 2013 Feb; 179(2):115-24.
    View in: PubMed
    Score: 0.079
  9. Radiobiological characterization of head and neck and sarcoma cells derived from patients prior to radiotherapy. Int J Radiat Oncol Biol Phys. 1990 Aug; 19(2):313-9.
    View in: PubMed
    Score: 0.067
  10. Diverse TNFalpha-induced death pathways are enhanced by inhibition of NF-kappaB. Int J Oncol. 2007 Dec; 31(6):1519-28.
    View in: PubMed
    Score: 0.056
  11. Cyclopamine increases the cytotoxic effects of paclitaxel and radiation but not cisplatin and gemcitabine in Hedgehog expressing pancreatic cancer cells. Cancer Chemother Pharmacol. 2006 Dec; 58(6):765-70.
    View in: PubMed
    Score: 0.050
  12. Transcriptional targeting of adenovirally delivered tumor necrosis factor alpha by temozolomide in experimental glioblastoma. Cancer Res. 2004 Sep 15; 64(18):6381-4.
    View in: PubMed
    Score: 0.045
  13. Histone H2AX phosphorylation as a predictor of radiosensitivity and target for radiotherapy. J Biol Chem. 2004 Jan 16; 279(3):2273-80.
    View in: PubMed
    Score: 0.042
  14. Repair of potentially lethal X ray damage and possible applications to clinical radiotherapy. Int J Radiat Oncol Biol Phys. 1983 Jan; 9(1):91-6.
    View in: PubMed
    Score: 0.040
  15. TNFerade Biologic: preclinical toxicology of a novel adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene. Cancer Gene Ther. 2002 Nov; 9(11):951-7.
    View in: PubMed
    Score: 0.039
  16. The differential response of human tumours to fractionated radiation may be due to a post-irradiation repair process. Br J Cancer. 1982 Oct; 46(4):532-7.
    View in: PubMed
    Score: 0.039
  17. Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance. Cancer J. 2002 Jan-Feb; 8(1):47-54.
    View in: PubMed
    Score: 0.037
  18. Evidence for the expression of radiation-induced potentially lethal damage being a p53-dependent process. Int J Radiat Biol. 2000 Aug; 76(8):1037-43.
    View in: PubMed
    Score: 0.034
  19. Lack of selective killing by steroids in normal and malignant cells. J Cell Physiol. 1980 Jun; 103(3):429-33.
    View in: PubMed
    Score: 0.033
  20. Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling. J Exp Med. 2020 05 04; 217(5).
    View in: PubMed
    Score: 0.033
  21. Tumor necrosis factor-alpha-based gene therapy enhances radiation cytotoxicity in human prostate cancer. Cancer Gene Ther. 1998 Nov-Dec; 5(6):344-9.
    View in: PubMed
    Score: 0.030
  22. Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft. Gene Ther. 1998 Mar; 5(3):293-300.
    View in: PubMed
    Score: 0.028
  23. Response of human osteosarcoma in vitro to irradiation: evidence for unusual cellular repair activity. Int J Radiat Biol Relat Stud Phys Chem Med. 1977 Mar; 31(3):295-9.
    View in: PubMed
    Score: 0.026
  24. Very low doses of ionizing radiation and redox associated modifiers affect survivin-associated changes in radiation sensitivity. Free Radic Biol Med. 2016 10; 99:110-119.
    View in: PubMed
    Score: 0.025
  25. DNA double-strand break rejoining rates, inherent radiation sensitivity and human tumour response to radiotherapy. Br J Cancer. 1996 Jul; 74(1):37-42.
    View in: PubMed
    Score: 0.025
  26. The role of intracellular calcium in the cellular response to ionizing radiation. Radiat Res. 1994 Jun; 138(3):392-400.
    View in: PubMed
    Score: 0.022
  27. The RAD51-stimulatory compound RS-1 can exploit the RAD51 overexpression that exists in cancer cells and tumors. Cancer Res. 2014 Jul 01; 74(13):3546-55.
    View in: PubMed
    Score: 0.022
  28. Chromosome changes characterizing in vitro response to radiation in human squamous cell carcinoma lines. Cancer Res. 1993 Nov 15; 53(22):5542-7.
    View in: PubMed
    Score: 0.021
  29. p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Res. 1993 Aug 15; 53(16):3667-9.
    View in: PubMed
    Score: 0.021
  30. Molecular targets to overcome radioresistance. Semin Oncol. 1992 Aug; 19(4 Suppl 11):14-20.
    View in: PubMed
    Score: 0.019
  31. Inhibition of protein kinases sensitizes human tumor cells to ionizing radiation. Radiat Res. 1992 Mar; 129(3):345-50.
    View in: PubMed
    Score: 0.019
  32. The interaction of 5-fluorouracil, hydroxyurea, and radiation in two human head and neck cancer cell lines. Oncology. 1992; 49(6):454-60.
    View in: PubMed
    Score: 0.019
  33. Epigenetic effects on radiosensitivity: the extracellular matrix and growth factors. Eur J Cancer. 1992; 28A(4-5):723-4.
    View in: PubMed
    Score: 0.019
  34. Mg ATP and antioxidants augment the radioprotective effect of surfactant copolymers. Health Phys. 2011 Dec; 101(6):731-8.
    View in: PubMed
    Score: 0.018
  35. Increased glutathione peroxidase activity in a human sarcoma cell line with inherent doxorubicin resistance. Cancer Res. 1991 Jan 15; 51(2):521-7.
    View in: PubMed
    Score: 0.017
  36. Cellular and molecular aspects of human tumor radioresistance. Important Adv Oncol. 1991; 73-83.
    View in: PubMed
    Score: 0.017
  37. The interaction between recombinant human tumor necrosis factor and radiation in 13 human tumor cell lines. Int J Radiat Oncol Biol Phys. 1990 Jul; 19(1):69-74.
    View in: PubMed
    Score: 0.017
  38. Radiobiological characterization of 53 human tumor cell lines. Int J Radiat Biol. 1989 Nov; 56(5):553-60.
    View in: PubMed
    Score: 0.016
  39. Sensitivities of NIH/3T3-derived clonal cell lines to ionizing radiation: significance for gene transfer studies. Cancer Res. 1989 Jun 15; 49(12):3396-400.
    View in: PubMed
    Score: 0.016
  40. Radioresistance of Stat1 over-expressing tumour cells is associated with suppressed apoptotic response to cytotoxic agents and increased IL6-IL8 signalling. Int J Radiat Biol. 2009 May; 85(5):421-31.
    View in: PubMed
    Score: 0.015
  41. Effect of antisense c-raf-1 on tumorigenicity and radiation sensitivity of a human squamous carcinoma. Science. 1989 Mar 10; 243(4896):1354-6.
    View in: PubMed
    Score: 0.015
  42. A chemical compound that stimulates the human homologous recombination protein RAD51. Proc Natl Acad Sci U S A. 2008 Oct 14; 105(41):15848-53.
    View in: PubMed
    Score: 0.015
  43. In vitro radiobiological parameters of human sarcoma cell lines. Int J Radiat Oncol Biol Phys. 1988 Oct; 15(4):937-42.
    View in: PubMed
    Score: 0.015
  44. Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy. Int J Radiat Oncol Biol Phys. 1988 Sep; 15(3):575-9.
    View in: PubMed
    Score: 0.015
  45. Southern analysis of human head and neck cancer cells for homologous sequences using yeast gamma repair genes. J Surg Oncol. 1988 Aug; 38(4):257-60.
    View in: PubMed
    Score: 0.015
  46. Heterogeneity of radiation response of a parent human epidermoid carcinoma cell line and four clones. Int J Radiat Oncol Biol Phys. 1988 May; 14(5):907-12.
    View in: PubMed
    Score: 0.014
  47. The maximum recovery potential of human tumor cells may predict clinical outcome in radiotherapy. Int J Radiat Oncol Biol Phys. 1987 May; 13(5):709-13.
    View in: PubMed
    Score: 0.013
  48. Radioresistant and repair proficient cells may determine radiocurability in human tumors. Int J Radiat Oncol Biol Phys. 1986 Apr; 12(4):637-9.
    View in: PubMed
    Score: 0.012
  49. Inherently radioresistant cells exist in some human tumors. Proc Natl Acad Sci U S A. 1985 Jul; 82(14):4732-5.
    View in: PubMed
    Score: 0.012
  50. Similar sensitivity of human lymphoblast cells proficient or deficient in nucleotide biosynthesis to the cytotoxic and cell cycle effects of 3-aminobenzamide. Exp Cell Res. 1985 Mar; 157(1):271-5.
    View in: PubMed
    Score: 0.012
  51. Modification by dexamethasone of radiation response of in vitro cultured cells. Int J Radiat Oncol Biol Phys. 1984 Nov; 10(11):2113-7.
    View in: PubMed
    Score: 0.011
  52. Interaction of amifostine and ionizing radiation on transcriptional patterns of apoptotic genes expressed in human microvascular endothelial cells (HMEC). Int J Radiat Oncol Biol Phys. 2004 Oct 01; 60(2):553-63.
    View in: PubMed
    Score: 0.011
  53. Poloxamer 188 prevents acute necrosis of adult skeletal muscle cells following high-dose irradiation. Burns. 2004 Sep; 30(6):539-47.
    View in: PubMed
    Score: 0.011
  54. The role of DNA repair processes in the response of human tumors to fractionated radiotherapy. Int J Radiat Oncol Biol Phys. 1984 Jul; 10(7):1127-34.
    View in: PubMed
    Score: 0.011
  55. Repair of fractionated radiation in plateau phase cultures of human tumor cells and human multicellular tumor spheroids. Radiother Oncol. 1984 Jun; 2(1):41-7.
    View in: PubMed
    Score: 0.011
  56. Cellular X-ray repair parameters of early passage squamous cell carcinoma lines derived from patients with known responses to radiotherapy. Br J Cancer. 1984 May; 49(5):595-601.
    View in: PubMed
    Score: 0.011
  57. An in vitro investigation of x-ray sensitivity in fibroblasts from patients with retinoblastoma. Invest Ophthalmol Vis Sci. 1983 Jul; 24(7):958-61.
    View in: PubMed
    Score: 0.010
  58. Sustained inhibition of experimental neointimal hyperplasia with a genetically modified herpes simplex virus. J Vasc Surg. 2003 Jun; 37(6):1294-300.
    View in: PubMed
    Score: 0.010
  59. Estrogen receptor-mediated cytotoxicity using iodine-125. J Cell Biochem. 1983; 21(1):39-45.
    View in: PubMed
    Score: 0.010
  60. In vitro radiosensitivity of fibroblasts derived from patients with retinoblastoma and abnormalities of chromosome 13. Retina. 1983; 3(2):126-30.
    View in: PubMed
    Score: 0.010
  61. Radioresistance in some human tumor cells conferred in vitro by repair of potentially lethal X-ray damage. Radiology. 1982 Nov; 145(2):511-3.
    View in: PubMed
    Score: 0.010
  62. Chemical modulation of the hypoxic fraction in the treatment of head and neck cancer. Ann Otol Rhinol Laryngol. 1982 Jul-Aug; 91(4 Pt 1):461-4.
    View in: PubMed
    Score: 0.010
  63. Fraction size and the repair of potentially lethal radiation damage in a human melanoma cell line. Possible implications for radiotherapy. Radiology. 1982 Jan; 142(1):225-7.
    View in: PubMed
    Score: 0.009
  64. Cellular repair factors influencing radiocurability of human malignant tumours. Br J Cancer. 1982 Jan; 45(1):10-6.
    View in: PubMed
    Score: 0.009
  65. In vitro radiosensitivity of human leukemia cell lines. Radiology. 1981 May; 139(2):485-7.
    View in: PubMed
    Score: 0.009
  66. The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin. J Biol Chem. 2000 Aug 04; 275(31):23899-903.
    View in: PubMed
    Score: 0.008
  67. Surfactant sealing of membranes permeabilized by ionizing radiation. Radiat Res. 2000 Aug; 154(2):171-7.
    View in: PubMed
    Score: 0.008
  68. X-ray sensitivity of human tumor cells in vitro. Int J Radiat Oncol Biol Phys. 1980 Apr; 6(4):437-40.
    View in: PubMed
    Score: 0.008
  69. Abnormal sensitivity of diploid skin fibroblasts from a family with gardner's syndrome to the lethal effects of X-irradiation, ultraviolet light and mitomycin-C. Mutat Res. 1980 Apr; 70(2):241-50.
    View in: PubMed
    Score: 0.008
  70. X-ray sensitivity of fifty-three human diploid fibroblast cell strains from patients with characterized genetic disorders. Cancer Res. 1980 Mar; 40(3):920-5.
    View in: PubMed
    Score: 0.008
  71. The essential functions of human Rad51 are independent of ATP hydrolysis. Mol Cell Biol. 1999 Oct; 19(10):6891-7.
    View in: PubMed
    Score: 0.008
  72. Combination hormonal, chemotherapy and radiotherapy in vitro: implications for therapy in vivo. Int J Radiat Oncol Biol Phys. 1979 Sep; 5(9):1657-61.
    View in: PubMed
    Score: 0.008
  73. DNA repair in a Fanconi's anemia fibroblast cell strain. Biochim Biophys Acta. 1979 Jan 26; 561(1):99-109.
    View in: PubMed
    Score: 0.008
  74. Deficient recovery from potentially lethal radiation damage in ataxia telengiectasia and xeroderma pigmentosum. Nature. 1978 Jan 19; 271(5642):261-2.
    View in: PubMed
    Score: 0.007
  75. Characterization and radiobiologic parameters of medulloblastoma in vitro. Cancer. 1977 Sep; 40(3):1087-96.
    View in: PubMed
    Score: 0.007
  76. Skin fibroblasts from a D-deletion type retinoblastoma patient are abnormally X-ray sensitive. Nature. 1977 Apr 21; 266(5604):726-7.
    View in: PubMed
    Score: 0.007
  77. Inherent cellular radiosensitivity of human tumors of varying clinical curability. AJR Am J Roentgenol. 1976 Dec; 127(6):1027-32.
    View in: PubMed
    Score: 0.007
  78. In vitro radiosensitivity of human dipliod fibroblasts derived from patients with unusual clinical responses to radiation. Radiology. 1976 Nov; 121(2):479-82.
    View in: PubMed
    Score: 0.006
  79. In vitro cellular radiosensitivity of human malignant tumors. Eur J Cancer (1965). 1976 Jan; 12(1):47-51.
    View in: PubMed
    Score: 0.006
  80. Effect of Bcl-2 on ionizing radiation and 1-beta-D-arabinofuranosylcytosine-induced internucleosomal DNA fragmentation and cell survival in human myeloid leukemia cells. Oncol Res. 1993; 5(3):139-44.
    View in: PubMed
    Score: 0.005
  81. cis-Diamminedichloroplatinum(II) induces c-jun expression in human myeloid leukemia cells: potential involvement of a protein kinase C-dependent signaling pathway. Cancer Res. 1992 Feb 15; 52(4):878-82.
    View in: PubMed
    Score: 0.005
  82. Radioresistant derivatives of radiosensitive CHO cells obtained following treatment with 5-azacytidine retain their sensitivity to cisplatin. Radiat Res. 1991 Aug; 127(2):226-9.
    View in: PubMed
    Score: 0.004
  83. Variation in radiation sensitivity during the cell cycle of two human squamous cell carcinomas. Int J Radiat Oncol Biol Phys. 1991 Apr; 20(4):733-8.
    View in: PubMed
    Score: 0.004
  84. Radioresistant derivatives of an X-ray-sensitive CHO cell line exhibit distinct patterns of sensitivity to DNA-damaging agents. Carcinogenesis. 1990 Aug; 11(8):1265-9.
    View in: PubMed
    Score: 0.004
  85. Platinum complexes inhibit repair of potentially lethal damage following bleomycin treatment. Br J Cancer. 1987 Mar; 55(3):245-8.
    View in: PubMed
    Score: 0.003
  86. Fibroblast radiosensitivity and intraocular fibrovascular proliferation following radiotherapy for bilateral retinoblastoma. Br J Ophthalmol. 1986 May; 70(5):336-42.
    View in: PubMed
    Score: 0.003
  87. Differing patterns of cytotoxicity of the phorbol ester 12-O-tetradecanoylphorbol 13-acetate in various human cell strains. Carcinogenesis. 1985 Dec; 6(12):1703-8.
    View in: PubMed
    Score: 0.003
  88. Comutagenic effects of 3-aminobenzamide in Chinese hamster ovary cells. Cancer Res. 1985 Apr; 45(4):1556-9.
    View in: PubMed
    Score: 0.003
  89. Investigation of the cytotoxic effects of DNA damaging agents on neurofibromatosis cells. Mutat Res. 1985 Jan-Feb; 142(1-2):55-8.
    View in: PubMed
    Score: 0.003
  90. Response of human fibroblasts to low dose rate gamma irradiation. Radiat Res. 1984 Nov; 100(2):387-95.
    View in: PubMed
    Score: 0.003
  91. Lethal effects of 1-beta-D-arabinofuranosylcytosine incorporation into deoxyribonucleic acid during ultraviolet repair. Mol Pharmacol. 1984 Mar; 25(2):322-6.
    View in: PubMed
    Score: 0.003
  92. Potentially lethal damage repair as a possible determinant of human tumour radiosensitivity. Radiother Oncol. 1984 Jan; 1(3):263-9.
    View in: PubMed
    Score: 0.003
  93. Work in progress: radioprotection of human breast cancer cells by elevation of intracellular cyclic AMP. Radiology. 1983 Jul; 148(1):289-90.
    View in: PubMed
    Score: 0.003
  94. Importance of repair of potentially lethal damage in assays of cytotoxic agents. Surgery. 1982 Aug; 92(2):380-4.
    View in: PubMed
    Score: 0.002
  95. Heterogeneous response to X-ray and ultraviolet light irradiations of cultured skin fibroblasts in two families with Gardner's Syndrome. J Natl Cancer Inst. 1982 May; 68(5):697-701.
    View in: PubMed
    Score: 0.002
  96. Iodine-125-labelled tamoxifen is differentially cytoxic to cells containing oestrogen receptors. Int J Radiat Biol Relat Stud Phys Chem Med. 1980 Aug; 38(2):197-202.
    View in: PubMed
    Score: 0.002
  97. Defective reactivation of ultraviolet light-irradiated herpesvirus by a Bloom's syndrome fibroblast strain. Cancer Res. 1979 Sep; 39(9):3392-6.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.